The effect of vaginally administered prostaglandin F2alpha on corpus luteum function.
D000328:Adult; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003338:Corpus Luteum / Q000187:drug effects* / Q000502:physiology; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008598:Menstruation / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D011374:Progesterone / Q000097:blood; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors; D014621:Vagina
D006063:Chorionic Gonadotropin; D004967:Estrogens; D011453:Prostaglandins; D011374:Progesterone; D007986:Luteinizing Hormone